SW · STMN.SW
Straumann Holding AG
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Basel 4002
- Website
- straumann.com
Price · as of 2025-12-31
$84.50
Market cap 14.3B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $62.09 | -26.52% |
| Intrinsic Value(DCF) | $37.25 | -55.92% |
| Graham-Dodd Method(GD) | $6.90 | -91.84% |
| Graham Formula(GF) | $26.78 | -68.3% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $13.07 | $32.02 | $1.99 | $0.93 | $1.09 |
| 2012 | $11.55 | $29.61 | $0.95 | $0.00 | $1.69 |
| 2013 | $16.39 | $32.75 | $2.46 | $1.34 | $4.70 |
| 2014 | $24.56 | $39.10 | $3.29 | $3.79 | $12.52 |
| 2015 | $29.93 | $40.40 | $4.28 | $0.00 | $9.03 |
| 2016 | $41.95 | $46.57 | $19.88 | $4.01 | $32.72 |
| 2017 | $59.18 | $56.62 | $65.95 | $6.83 | $50.03 |
| 2018 | $78.46 | $65.33 | $115.40 | $6.45 | $51.27 |
| 2019 | $65.36 | $56.74 | $119.74 | $7.34 | $47.15 |
| 2020 | $106.37 | $70.20 | $9.28 | $0.00 | $0.00 |
| 2021 | $140.21 | $100.31 | $127.04 | $10.56 | $119.80 |
| 2022 | $124.18 | $87.03 | $108.92 | $11.86 | $60.82 |
| 2023 | $140.91 | $91.56 | $70.73 | $3.64 | $18.46 |
| 2024 | $113.21 | $80.41 | $4.56 | $8.51 | $28.66 |
| 2025 | $89.68 | $62.09 | $2.25 | $6.89 | $26.78 |
AI valuation
Our deep-learning model estimates Straumann Holding AG's (STMN.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $62.09
- Current price
- $84.50
- AI upside
- -26.52%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$37.25
-55.92% upside
Graham-Dodd
$6.90
-91.84% upside
Graham Formula
$26.78
-68.3% upside
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
- CEO
- Guillaume Daniellot
- Employees
- 11.34K
- Beta
- 1.51
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($37.25 ÷ $84.50) − 1 = -55.92% (DCF, example).